Abstract
In 1978 adenosine monophosphate (AMP) deaminase deficiency in skeletal muscle (“myoadenylate deaminase deficiency”) was described as a new entity by Fishbein et al. Their publication, “Myoadenylate deaminase deficiency: a new disease of muscle,” reported five patients with muscular weakness or cramping after exercise. Muscle biopsies of all five patients showed less than 5% of normal AMP deaminase activity, levels of other enzymes were normal. Routine histology of skeletal muscle was also normal. The symptoms of these patients were attributed to the lack of AMP deaminase activity.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
